Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage

医学 抗血栓 脑出血 冲程(发动机) 心房颤动 不利影响 随机对照试验 内科学 危险系数 心脏病学 抗血小板药物 阿司匹林 氯吡格雷 置信区间 机械工程 蛛网膜下腔出血 工程类
作者
Rustam Al‐Shahi Salman,Steven Mark Greenberg
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:54 (12): 3173-3181 被引量:16
标识
DOI:10.1161/strokeaha.123.036886
摘要

This focused update about antiplatelet agents to reduce the high risk of major adverse cardiovascular events after stroke due to spontaneous (nontraumatic) intracerebral hemorrhage (ICH) complements earlier updates about blood pressure-lowering, lipid-lowering, and oral anticoagulation or left atrial appendage occlusion for atrial fibrillation after ICH. When used for secondary prevention in people without ICH, antiplatelet agents reduce the risk of major adverse cardiovascular event (rate ratio, 0.81 [95% CI, 0.75–0.87]) and might increase the risk of ICH (rate ratio, 1.67 [95% CI, 0.97–2.90]). Before 2019, guidance for clinical decisions about antiplatelet agent use after ICH has focused on estimating patients’ predicted absolute risks and severities of ischemic and hemorrhagic major adverse cardiovascular event and applying the known effects of these drugs in people without ICH to estimate whether individual ICH survivors in clinical practice might be helped or harmed by antiplatelet agents. In 2019, the main results of the RESTART (Restart or Stop Antithrombotics Randomized Trial) randomized controlled trial including 537 survivors of ICH associated with antithrombotic drug use showed, counterintuitively, that antiplatelet agents might not increase the risk of recurrent ICH compared to antiplatelet agent avoidance over 2 years of follow-up (12/268 [4%] versus 23/268 [9%]; adjusted hazard ratio, 0.51 [95% CI, 0.25–1.03]; P =0.060). Guidelines in the United States, Canada, China, and the United Kingdom and Ireland have classified the level of evidence as B and indicated that antiplatelet agents may be considered/reasonable after ICH associated with antithrombotic agent use. Three subsequent clinical trials have recruited another 174 participants with ICH, but they will not be sufficient to determine the effects of antiplatelet therapy on all major adverse cardiovascular events reliably when pooled with RESTART. Therefore, ASPIRING (Antiplatelet Secondary Prevention International Randomized Study After Intracerebral Hemorrhage) aims to recruit 4148 ICH survivors to determine the effects of antiplatelet agents after ICH definitively overall and in subgroups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
香蕉觅云的应助被科研通管家采纳,获得10
刚刚
cookie完成签到,获得积分10
刚刚
bkagyin的应助被科研通管家采纳,获得10
刚刚
FashionBoy的应助被科研通管家采纳,获得10
刚刚
orixero的应助被科研通管家采纳,获得10
刚刚
刚刚
Jasper的应助被科研通管家采纳,获得10
刚刚
1秒前
1秒前
荷序发布了新的文献求助10
1秒前
1秒前
所所的应助被科研通管家采纳,获得10
1秒前
safari完成签到 ,获得积分10
2秒前
芦苇发布了新的文献求助10
2秒前
Youdge的应助被科研通管家采纳,获得20
2秒前
Orange的应助被唐璜采纳,获得10
2秒前
CipherSage的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
syvshc的应助被科研通管家采纳,获得10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
鲸落小小的应助被科研通管家采纳,获得10
2秒前
李爱国的应助被科研通管家采纳,获得10
3秒前
3秒前
wanci的应助被77777采纳,获得10
3秒前
酥酥完成签到,获得积分10
3秒前
李健的应助被吱吱采纳,获得20
3秒前
乐乐的应助被科研通管家采纳,获得10
3秒前
开朗映秋完成签到,获得积分10
3秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
3秒前
qianzhihe发布了新的文献求助10
3秒前
3秒前
3秒前
怡神001完成签到,获得积分10
3秒前
852的应助被MingFei采纳,获得10
3秒前
3秒前
4秒前
CodeCraft的应助被科研通管家采纳,获得30
4秒前
香蕉觅云的应助被科研通管家采纳,获得10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188177
求助须知:如何正确求助?哪些是违规求助? 9575987
关于积分的说明 21844723
捐赠科研通 7785975
什么是DOI,文献DOI怎么找? 3435220
关于科研通互助平台的介绍 2559558
邀请新用户注册赠送积分活动 2482095